107 related articles for article (PubMed ID: 10582729)
1. Minimal persistent inflammation may be controlled by cetirizine.
Canonica GW; Ciprandi G
Ann Allergy Asthma Immunol; 1999 Nov; 83(5):445-8. PubMed ID: 10582729
[TBL] [Abstract][Full Text] [Related]
2. Cetirizine reduces ICAM-I on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite-allergic asthma.
Fasce L; Ciprandi G; Pronzato C; Cozzani S; Tosca MA; Grimaldi I; Canonica GW
Int Arch Allergy Immunol; 1996 Mar; 109(3):272-6. PubMed ID: 8620097
[TBL] [Abstract][Full Text] [Related]
3. Cetirizine reduces conjunctival nonspecific hyperreactivity in children with mite allergy.
Tosca M; Ciprandi G; Passalacqua G; Canonica GW
J Investig Allergol Clin Immunol; 1998; 8(1):23-6. PubMed ID: 9555615
[TBL] [Abstract][Full Text] [Related]
4. Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activity.
Ciprandi G; Tosca M; Ricca V; Passalacqua G; Riccio AM; Bagnasco M; Canonica GW
Clin Exp Allergy; 1997 Oct; 27(10):1160-6. PubMed ID: 9383256
[TBL] [Abstract][Full Text] [Related]
5. Long-term cetirizine treatment may reduce new sensitisations in allergic children: a pilot study.
Ciprandi G; Frati F; Marcucci F; Sensi L; Milanese M; Tosca MA
Eur Ann Allergy Clin Immunol; 2003 Jun; 35(6):208-11. PubMed ID: 12872679
[TBL] [Abstract][Full Text] [Related]
6. Long-term cetirizine treatment reduces allergic symptoms and drug prescriptions in children with mite allergy.
Ciprandi G; Tosca M; Passalacqua G; Canonica GW
Ann Allergy Asthma Immunol; 2001 Sep; 87(3):222-6. PubMed ID: 11570619
[TBL] [Abstract][Full Text] [Related]
7. The comparison of the efficacy and safety of cetirizine, oxatomide, ketotifen, and a placebo for the treatment of childhood perennial allergic rhinitis.
Lai DS; Lue KH; Hsieh JC; Lin KL; Lee HS
Ann Allergy Asthma Immunol; 2002 Dec; 89(6):589-98. PubMed ID: 12487225
[TBL] [Abstract][Full Text] [Related]
8. Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression.
Ciprandi G; Pronzato C; Ricca V; Passalacqua G; Danzig M; Canonica GW
Clin Exp Allergy; 1997 Oct; 27(10):1175-83. PubMed ID: 9383258
[TBL] [Abstract][Full Text] [Related]
9. Effects of minimal persistent inflammation on nasal mucosa of experimental allergic rhinitis.
Lei F; Zhu D; Sun J; Dong Z
Am J Rhinol Allergy; 2010; 24(1):e23-8. PubMed ID: 20109315
[TBL] [Abstract][Full Text] [Related]
10. Expression of ICAM-1 on conjunctival epithelium and ECP in tears and serum from children with allergic conjunctivitis.
Oh JW; Shin JC; Jang SJ; Lee HB
Ann Allergy Asthma Immunol; 1999 Jun; 82(6):579-85. PubMed ID: 10400487
[TBL] [Abstract][Full Text] [Related]
11. Azelastine eye drops reduce conjunctival hyperresponsiveness to hyperosmolar glucose challenge in children with asymptomatic mite conjunctivitis.
Ciprandi G; Catrullo A; Tosca M; Cerqueti P; Mondino C; Passalacqua G; Canonica GW
J Investig Allergol Clin Immunol; 1999; 9(1):35-8. PubMed ID: 10212855
[TBL] [Abstract][Full Text] [Related]
12. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy.
Ciprandi G; Buscaglia S; Pesce G; Pronzato C; Ricca V; Parmiani S; Bagnasco M; Canonica GW
J Allergy Clin Immunol; 1995 Dec; 96(6 Pt 1):971-9. PubMed ID: 8543756
[TBL] [Abstract][Full Text] [Related]
13. [Oral second generation antihistamines in allergic rhinitis].
Riechelmann H
Laryngorhinootologie; 2005 Jan; 84(1):30-41. PubMed ID: 15647976
[TBL] [Abstract][Full Text] [Related]
14. Impact of cetirizine on the burden of allergic rhinitis.
Meltzer EO; Grant JA
Ann Allergy Asthma Immunol; 1999 Nov; 83(5):455-63. PubMed ID: 10582731
[TBL] [Abstract][Full Text] [Related]
15. A two-year course of specific immunotherapy or of continuous antihistamine treatment reverse eosinophilic inflammation in severe persistent allergic rhinitis.
Lauriello M; Muzi P; Di Rienzo L; Di Stanislao C; Tirelli GC; Bologna M
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):284-91. PubMed ID: 16602327
[TBL] [Abstract][Full Text] [Related]
16. Azelastine eye drops reduce and prevent allergic conjunctival reaction and exert anti-allergic activity.
Ciprandi G; Buscaglia S; Catrullo A; Pesce G; Fiorino N; Montagna P; Bagnasco M; Canonica GW
Clin Exp Allergy; 1997 Feb; 27(2):182-91. PubMed ID: 9061218
[TBL] [Abstract][Full Text] [Related]
17. Cetirizine reduces cytokines and inflammatory cells in children with perennial allergic rhinitis.
Ciprandi G; Tosca MA; Milanese M; Ricca V
Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):237-40. PubMed ID: 15329007
[TBL] [Abstract][Full Text] [Related]
18. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child.
Pediatr Allergy Immunol; 1998 Aug; 9(3):116-24. PubMed ID: 9814724
[TBL] [Abstract][Full Text] [Related]
19. Preliminary evidence for 'aberrant' expression of the leukocyte integrin LFA-1 (CD11a/CD18) on conjunctival epithelial cells of patients with mite allergy.
Pesce G; Ciprandi G; Buscaglia S; Fiorino N; Salmaso C; Riccio AM; Canonica GW; Bagnasco M
Int Arch Allergy Immunol; 2001 Jun; 125(2):160-3. PubMed ID: 11435733
[TBL] [Abstract][Full Text] [Related]
20. Antiallergic anti-inflammatory effects of H1-antihistamines in humans.
Assanasen P; Naclerio RM
Clin Allergy Immunol; 2002; 17():101-39. PubMed ID: 12113215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
